6 SEGMENT INFORMATION
The Company does not distinguish different operating segments.
The income was derived from five pharmaceutical partners, namely AbbVie, Merck KGaA, Merck & Co., Inc., Sanofi and Novo Nordisk. Moreover, in 2017 more than 80% of the income originated from three parties, one party was responsible for 29% of the income, two other parties represented 27% each.
In 2016 more than 85% of the income originated from three parties, one party was responsible for more than 40% of the income, two other parties represented between 19% and 25% each. In 2015, one party represented more than 50% of the revenues, two other parties represented between 15% and 23% each.